DF
EW icon

Dunhill Financial’s Edwards Lifesciences EW Stock Holding History

Dunhill Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72K Buy
19
+9
+90% +$754 ﹤0.01% 902
2026
Q1 		$826 Sell
10
-10
-50% -$824 ﹤0.01% 1004
2025
Q4 		$1.71K Buy
20
+7
+54% +$574 ﹤0.01% 768
2025
Q3 		$1K Sell
13
-7
-35% -$547 ﹤0.01% 772
2025
Q2 		$1.59K Sell
20
-123
-86% -$9.17K ﹤0.01% 720
2025
Q1 		$10.3K Sell
143
-10
-7% -$716 ﹤0.01% 407
2024
Q4 		$11.3K Buy
153
+30
+24% +$2.1K 0.01% 353
2024
Q3 		$8.11K Buy
123
+65
+112% +$4.72K ﹤0.01% 439
2024
Q2 		$5.4K Buy
58
+11
+23% +$974 ﹤0.01% 385
2024
Q1 		$4.45K Buy
47
+8
+21% +$672 ﹤0.01% 335
2023
Q4 		$2.99K Buy
+39
New +$2.71K ﹤0.01% 378

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dunhill Financial's EW Position: Q2 2026 in Review

Dunhill Financial increased its Edwards Lifesciences (EW) stake by 90% in Q2 2026, buying an estimated $754 and bringing the position to 19 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Dunhill Financial first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.3K in Q4 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Dunhill Financial held 19 shares of Edwards Lifesciences worth $1.72K as of Q2 2026.
  • Dunhill Financial bought 9 Edwards Lifesciences shares in Q2 2026, an estimated $754.
  • Edwards Lifesciences made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #902 holding.
  • Dunhill Financial first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Edwards Lifesciences position peaked at $11.3K in Q4 2024.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.